East Crystal Technology's IPO on the ChiNext board has received inquiries, HV-SEM has achieved machine output and is currently undergoing industrial validation.

date
07:00 17/07/2026
avatar
GMT Eight
On July 16, Zhonghao Microelectronics Technology (Beijing) Co., Ltd. (referred to as Zhonghao Microelectronics) applied to the Shanghai Stock Exchange's Science and Technology Innovation Board for a change in the status of its listing review to "under inquiry." CICC is the sponsor institution and plans to raise 2.5 billion yuan.
On July 16, Dongfang Jingyuan Microelectronics Technology (Beijing) Co., Ltd. (referred to as Dongfang Jingyuan) applied for a change in the status of Shanghai Stock Exchange's Sci-Tech Innovation Board listing review to "inquiry received," with China Securities Co., Ltd. as the sponsor. They plan to raise 2.5 billion RMB. According to the prospectus, Dongfang Jingyuan's main business is the research, development, production, and sales of integrated circuit inspection equipment, as well as the research and sales of integrated circuit manufacturing EDA software, aiming to address the yield pain points in chip manufacturing. They provide customers with comprehensive solutions for improving chip manufacturing yield by combining hardware products of inspection equipment, manufacturing EDA software products, and different products organically. The latest models of CD-SEM and DR-SEM from Dongfang Jingyuan have received bulk orders from customer G, and verification results show that the technical indicators of the company's products are comparable to mainstream equipment from international manufacturers. The company's EBI equipment is the first domestically developed and industrially validated electron beam defect detection equipment, which has been in mass production for over 5 years, with continuous performance iteration and continuous acquisition of new customer orders. The HV-SEM has been successfully launched and is undergoing industrial validation. Financially, the company achieved operating revenues of approximately 191 million RMB, 375 million RMB, and 317 million RMB in the fiscal years 2023, 2024, and 2025, respectively. During the same period, they had net losses of -239 million RMB, -150 million RMB, and -478 million RMB. At the end of each reporting period, the company's consolidated asset-liability ratios were 43.97%, 51.69%, and 81.52%, showing a rapid upward trend. The high asset-liability ratio puts the company under certain financial pressure. If future revenue growth falls short of expectations, downstream customer repayment cycles extend, or macro monetary policy tightening leads to a contraction in bank credit lines, the company may face a situation of tight cash flow turnover, which could have a negative impact on the company's normal production and operations.